JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇧🇷🏛️

Regulatory Hierarchy

Brazilian regulatory structure for medicinal cannabis

Regulatory Structure Verified 2026-04-20

Workflow steps

  1. ANVISA — Agência Nacional de Vigilância Sanitária
    Primary regulator for medicinal cannabis. RDC 327/2019 is the primary regulation governing cannabis-derived products. ANVISA oversees product registration, import authorization, and manufacturing standards.
    • Product registration (RDC 327/2019)
    • Import authorization
    • Manufacturing standards (BPF)
    • GMP oversight for domestic production
  2. Ministry of Health — Ministério da Saúde
    Policy oversight of ANVISA. Sets national medicinal cannabis policy. Brazil does not yet cover cannabis medicines under SUS (public health system).
    • National drug policy
    • Oversight of ANVISA
    • SUS coverage decisions (pending)
  3. ANVISA Regional Offices — State-level enforcement (VISA)
    Vigilância Sanitária (VISA) offices enforce ANVISA regulations at the state level. Conduct facility inspections and monitor compliance.
    • State-level facility inspections
    • Compliance monitoring
    • Enforcement of ANVISA standards
  4. Pharmacies — Dispensing
    Dispensing of ANVISA-registered cannabis products. Growing private market as access expands. No SUS coverage — patients pay out-of-pocket.
    • Pharmacy license
    • ANVISA-registered products only
    • Prescription required
  5. Patients — End recipients
    Growing patient access. No SUS (public health) coverage yet — all cannabis medicines paid privately. Brazil is the LARGEST Latin American medical cannabis market.
Import Authorization